Axonova Medical, LLC
Publicly observedPhiladelphia, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Philadelphia | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Axonova Medical, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | DLUMA6JAZ1K4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Jan 2022Publicly observed
NIH SBIR/STTR award: Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons
USD 902,542.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant15 Jan 2022Publicly observed
NIH SBIR/STTR award: Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons
USD 1,099,609.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.